| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |